China Wholesale Matcha Antioxidants Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

With a positive and progressive attitude to customer's interest, our enterprise continually improves our products excellent to meet the wants of customers and further focuses on safety, reliability, environmental requirements, and innovation of Uva And Uvb Sunscreen , Luxurious Sunscreen , Inorganic Uv Filters , Create Values,Serving Customer!" is the aim we pursue. We sincerely hope that all customers will establish long term and mutually beneficial cooperation with us.If you wish to get more details about our company, Please contact with us now.
China Wholesale Matcha Antioxidants Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma Detail:

Product Paramete

Trade name PromaCare-TA
CAS 1197-18-8
Product Name Tranexamic Acid
Chemical Structure
Application Medicine
Package 25kgs net per drum
Appearance White or almost white, crystalline power
Assay 99.0-101.0%
Solubility Water soluble
Shelf life 4 years
Storage Keep container tightly closed and in a cool place. Keep away from heat.

Application

Tranexamic Acid, also known as clotting acid, is an antifibrinolytic amino acid, which is one of the commonly used anticoagulants in clinic

This product can be used for:

1. Trauma or surgical bleeding of prostate, urethra, lung, brain, uterus, adrenal gland, thyroid, liver and other organs rich in plasminogen activator.

2. They are used as thrombolytic agents, such as tissue plasminogen activator (t-PA), streptokinase and urokinase antagonist.

3. Induced abortion, placental exfoliation, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding.

4. Menorrhagia, anterior chamber hemorrhage and severe epistaxis with increased local fibrinolysis.

5. It is used to prevent or reduce bleeding after tooth extraction or oral surgery in hemophilic patients with factor VIII or factor IX deficiency.

6. This product is superior to other antifibrinolytic drugs in hemostasis of mild hemorrhage caused by rupture of central aneurysm, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage. However, attention must be paid to the risk of cerebral edema or cerebral infarction. As for severe patients with surgical indications, this product can only be used as an adjuvant.

7. For the treatment of hereditary vascular edema, can reduce the number of attacks and severity.

8. Patients with hemophilia have active bleeding.

9. It has definite curative effect on chloasma.


Product detail pictures:

China Wholesale Matcha Antioxidants Factory Suppliers - PromaCare-TA / Tranexamic Acid  – Uniproma detail pictures


Related Product Guide:

We are going to make every single effort for being excellent and excellent, and accelerate our ways for standing while in the rank of international top-grade and high-tech enterprises for China Wholesale Matcha Antioxidants Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma, The product will supply to all over the world, such as: Yemen, Holland, Iraq, With the development and enlargement of mass clients abroad, now we've set up cooperative relationships with many major brands. We've our own factory and also have many reliable and well-cooperated factories in the field. Adhering to the "quality first, customer first, We are provideing high-quality, low-cost items and first-class service to customers. We sincerely hope to establish business relationship with customers from all over the world on the basis of quality, mutually benefit. We welcome OEM projects and designs.
  • Adhering to the business principle of mutual benefits, we have a happy and successful transaction, we think we will be the best business partner.
    5 Stars By Chris Fountas from Switzerland - 2018.09.23 17:37
    The supplier abide the theory of "quality the basic, trust the first and management the advanced" so that they can ensure a reliable product quality and stable customers.
    5 Stars By Matthew Tobias from Czech Republic - 2017.01.11 17:15